Navigation Links
AutoImmune Inc. Reports 2007 Third Quarter Financial Results
Date:11/8/2007

PASADENA, Calif., Nov. 8 /PRNewswire-FirstCall/ -- AutoImmune Inc. (OTCBB: AIMM) today reported a net loss of $8,000, or break even per share basic and diluted, for the three months ended September 30, 2007, compared with a net loss of $36,000, or break even per share basic and diluted, for the three months ended September 30, 2006. For the nine months ended September 30, 2007, the net loss was $62,000, or break even per share basic and diluted, compared with net loss of $517,000, or $0.03 per share basic and diluted for the same period in 2006. As of September 30, 2007, the Company reported $8.7 million in cash and marketable securities as compared to $8.8 million in cash and marketable securities as of December 31, 2006.

Chairman of the Board and Chief Executive Officer Robert C. Bishop, Ph.D. stated, "Product sales at Colloral LLC, our joint venture with Deseret Laboratories, Inc., were disappointing in the quarter just ended, but we remain optimistic they will increase in coming months. While sales through GNC have ceased, Bronson Laboratories LLC is selling the product through its catalogs, and Colloral LLC began marketing the product through The Shopping Channel in Canada in early October." AutoImmune consolidates Colloral LLC for financial reporting purposes in accordance with FIN 46 "Consolidation of Variable Interest Entities."

AutoImmune has exclusively licensed certain of its intellectual property rights to BioMS Medical Corp., a Canadian company. Under the license agreement, BioMS makes monthly diligence payments to AutoImmune and will pay royalties to AutoImmune on sales of its lead drug MBP8298, if it reaches the market. BioMS recently reported that 70% of the patients screened for their first pivotal trial in secondary multiple sclerosis have the HLA-DR2/DR4 genes that are believed to make them responsive to therapy with MBP8298. Interim results from this trial are expected in May 2008.

AutoImmune is a biopharmaceutical compan
'/>"/>

SOURCE AutoImmune Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. M.D. Anderson-led team reports possible key to autoimmune disease
2. Occupational exposures may be linked to death from autoimmune disease
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... Mullin/Ashley ... recognized in the 2015 Aster Awards national competition for a marketing communications campaign ... City and surrounding communities in Coastal Maryland and Southern Delaware. , A Bronze ...
(Date:7/31/2015)... ... July 31, 2015 , ... Like nearly every other form ... been advanced, upgraded, made more effective and less intrusive and painful. Leading these ... Enlargement Center. Dr. Loria currently stands as the only doctor in the United ...
(Date:7/31/2015)... New York, NY and Rockport, ME (PRWEB) , ... July 31, 2015 , ... The ... this photo op. , Glancing out of the window, he recalled that his equipment ... 215 Chrystie Street tower, he jumped out of bed. , The photo speaks ...
(Date:7/31/2015)... ... , ... Ticket Down is a reputable source of authentic USA vs. ... will face the Australia Women's National Team in two separate friendly contests. The ... and the second match will occur in Birmingham, Alabama at Legion Field. These ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of authentic ... Soccer Team will face the Australia Women's National Team in conjunction with their Victory Tour ... 5-2. Carli Lloyd from the USA team was awarded the Golden Ball as the ...
Breaking Medicine News(10 mins):Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Cheap USA vs. Australia Tickets at Ford Field in Detroit, MI: Ticket Down Slashes Ticket Prices for Australia vs. USWNT International Friendly Match at Ford Field 2
... are calling on the Federal Government to fund a new ... ,Rotavirus puts 10,000 Australian children in hospital each year, ... at doctors' surgeries with symptoms of acute diarrhoea and vomiting. ... aged six to 32 weeks, is only available by private ...
... to be "alarmingly dismal" with over 180 million urban poor ... says an industry analysis. ,At least 300 additional ... up annually to cater to the needs of 215 million ... Chambers of Commerce and Industry of India (ASSOCHAM). ...
... information management device by Intel and Motion Computing, is no ... that it is starting to ship the device to hospitals ... with patients, do their jobs on the move while remaining ... an impressive array of features such as a camera, RFID ...
... tobacco industry memo from 1969. For half a century, the ... cancer. Now, with that effort long since failed, cigarette producers ... to manufacture doubt. ,"The tobacco industry is now ... everyone knew but no one had proof," said Robert N. ...
... its distinguishing shape? Shape may be formed by cell movement, ... of which react to// influences from the local environment. Initially, ... to develop into cardiac chambers. ,In a new ... Heidi Auman, Deborah Yelon, and colleagues found, by using transgenic ...
... experts Fred R. Volkmar, M.D., and Ami Klin are part ... an individual gene and a// region of a chromosome that ... are published online in Nature Genetics and also will be ... on the largest autism genome scan done to date. The ...
Cached Medicine News:Health News:Call for Rotavirus Vaccine Funding 2Health News:Urban Poor in Dire Need of Proper Healthcare: Report 2Health News:Tobacco Companies Obstructed Science 2Health News:Tobacco Companies Obstructed Science 3Health News:Autism Gene Identified by Yale and Global Consortium 2
(Date:7/31/2015)... , July 31, 2015 Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of its previously announced underwritten public offering of ... public offering price of $11.25 per share. The ... 1,000,000 shares issued upon the exercise in full ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015  Eisai ... Ltd. (Headquarters: Tokyo , President and ... Inc. (Headquarters: San Diego, California , ... HALO") have signed a clinical collaboration agreement to evaluate ... in combination with Halozyme,s investigational drug PEGPH20 (PEGylated recombinant ...
(Date:7/31/2015)... , July 31, 2015 According ... Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray Absorptiometry ... Weighing) - Global Analysis & Forecast to 2019", published ... pegged at $911.1 Million 2014 and is estimated to ... CAGR of 9.4% from 2014 to 2019. ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... 15, 2011 Millennium HealthCare Inc. ... LLP, a Public Company Accounting Oversight Board (PCAOB) accounting ... KBL, LLP provides a combination of technology, ... businesses. Their professionals maintain an entrepreneurial spirit and a ...
... US, LLC ("Astellas") recently named Percival Barretto-Ko as ... a new position added to the company,s leadership ... Barretto-Ko will be responsible for corporate planning, business ... government affairs. "This realignment brings key ...
Cached Medicine Technology:Millennium HealthCare Inc. Engages KBL, LLP 2Astellas Expands Leadership Team With Senior Vice President of Corporate Strategy and Government Affairs 2
... duty chair with electrical operation with ... and seat rotation with click stops ... heavy duty chair with electrical operation ... mm and seat rotation with click ...
Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option....
Portable mini halogen light....
The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
Medicine Products: